Duncker Streett & Co’s Zimmer Biomet ZBH Stock Holding History

Duncker Streett & Co’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$353K	Hold	3,906	–	–	0.07%	196
2025 Q4	$351K	Hold	3,906	–	–	0.06%	188
2025 Q3	$385K	Hold	3,906	–	–	0.07%	184
2025 Q2	$356K	Sell	3,906 -60	-2%	-$5.8K	0.07%	184
2025 Q1	$449K	Hold	3,966	–	–	0.09%	157
2024 Q4	$419K	Sell	3,966 -24	-0.6%	-$2.58K	0.08%	169
2024 Q3	$431K	Hold	3,990	–	–	0.08%	167
2024 Q2	$433K	Hold	3,990	–	–	0.08%	158
2024 Q1	$527K	Sell	3,990 -146	-4%	-$18.2K	0.1%	150
2023 Q4	$503K	Sell	4,136 -30	-0.7%	-$3.35K	0.11%	145
2023 Q3	$468K	Hold	4,166	–	–	0.11%	143
2023 Q2	$607K	Sell	4,166 -4	-0.1%	-$544	0.14%	137
2023 Q1	$539K	Sell	4,170 -100	-2%	-$12.6K	0.13%	142
2022 Q4	$544K	Hold	4,270	–	–	0.13%	143
2022 Q3	$446K	Sell	4,270 -101	-2%	-$11.1K	0.12%	151
2022 Q2	$459K	Buy	4,371 +51	+1%	+$6.05K	0.11%	158
2022 Q1	$553K	Sell	4,320 -130	-3%	-$15.7K	0.11%	160
2021 Q4	$549K	Buy	4,450 +1,093	+33%	+$143K	0.09%	171
2021 Q3	$477K	Hold	3,357	–	–	0.09%	177
2021 Q2	$524K	Sell	3,357 -1,276	-28%	-$207K	0.1%	174
2021 Q1	$720K	Sell	4,633 -79	-2%	-$12.2K	0.14%	149
2020 Q4	$705K	Sell	4,712 -42	-0.9%	-$5.93K	0.14%	144
2020 Q3	$628K	Sell	4,754 -93	-2%	-$12.1K	0.14%	135
2020 Q2	$562K	Sell	4,847 -618	-11%	-$71.2K	0.13%	150
2020 Q1	$537K	Sell	5,465 -40	-0.7%	-$5.24K	0.14%	146
2019 Q4	$800K	Hold	5,505	–	–	0.17%	136
2019 Q3	$733K	Sell	5,505 -103	-2%	-$13.3K	0.17%	137
2019 Q2	$641K	Sell	5,608 -25	-0.4%	-$2.93K	0.14%	155
2019 Q1	$699K	Sell	5,633 -107	-2%	-$12.2K	0.16%	144
2018 Q4	$578K	Hold	5,740	–	–	0.15%	150
2018 Q3	$733K	Buy	5,740 +16	+0.3%	+$1.9K	0.17%	146
2018 Q2	$619K	Buy	5,724 +189	+3%	+$20.6K	0.15%	154
2018 Q1	$586K	Buy	5,535 +319	+6%	+$37K	0.15%	161
2017 Q4	$611K	Hold	5,216	–	–	0.16%	157
2017 Q3	$593K	Hold	5,216	–	–	0.18%	147
2017 Q2	$650K	Sell	5,216 -193	-4%	-$22.9K	0.2%	135
2017 Q1	$641K	Buy	5,409 +181	+3%	+$20.5K	0.2%	135
2016 Q4	$524K	Buy	5,228 +119	+2%	+$12.8K	0.17%	143
2016 Q3	$645K	Buy	5,109 +93	+2%	+$11.5K	0.22%	124
2016 Q2	$586K	Sell	5,016 -558	-10%	-$63.2K	0.21%	128
2016 Q1	$577K	Sell	5,574 -42	-0.7%	-$4.06K	0.21%	124
2015 Q4	$560K	Buy	5,616 +559	+11%	+$54.7K	0.21%	126
2015 Q3	$461K	Hold	5,057	–	–	0.18%	137
2015 Q2	$537K	Hold	5,057	–	–	0.19%	139
2015 Q1	$578K	Sell	5,057 -52	-1%	-$5.93K	0.19%	136
2014 Q4	$563K	Hold	5,109	–	–	0.18%	142
2014 Q3	$498K	Sell	5,109 -25	-0.5%	-$2.46K	0.17%	151
2014 Q2	$517K	Hold	5,134	–	–	0.17%	159
2014 Q1	$472K	Hold	5,134	–	–	0.17%	157
2013 Q4	$465K	Buy	5,134 +193	+4%	+$16.7K	0.17%	154
2013 Q3	$394K	Hold	4,941	–	–	0.16%	160
2013 Q2	$360K	Buy	+4,941	New	+$369K	0.14%	172

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Duncker Streett & Co's ZBH Position: Q1 2026 in Review

Duncker Streett & Co held its Zimmer Biomet (ZBH) position steady in Q1 2026 at 3,906 shares worth $353K. The position accounts for 0.07% of the portfolio, ranked #196.

Duncker Streett & Co first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $800K in Q4 2019. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Duncker Streett & Co held 3,906 shares of Zimmer Biomet worth $353K as of Q1 2026.
Duncker Streett & Co left its Zimmer Biomet share count unchanged in Q1 2026.
Zimmer Biomet made up 0.07% of Duncker Streett & Co's portfolio in Q1 2026, its #196 holding.
Duncker Streett & Co first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
Duncker Streett & Co's Zimmer Biomet position peaked at $800K in Q4 2019.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Duncker Streett & Co's 13F filing for Q1 2026, filed 29 Apr 2026.